Page 2 of 2 Previous

Continued: New research: Some women may be able to safely skip certain breast cancer treatments

  • Article by: MARILYNN MARCHIONE , Associated Press
  • Last update: December 11, 2013 - 1:32 PM

For every 100 women given radiation, "one will have a recurrence anyway, four will have a recurrence prevented, but 95 will have had unnecessary treatment," Kunkler said. Since radiation did not affect survival or the risk of cancer spreading, skipping it "is a reasonable option."

"LIGHT" CHEMO

Doctors are unsure how to treat women with small tumors involving the gene that the drug Herceptin targets. Those tumors are low risk because they're still confined to the breast, but high risk because the gene is thought to make them more aggressive. Some women get heavy-duty chemo, including drugs that can damage the heart.

Dr. Eric Winer of the Dana-Farber Cancer Institute in Boston led a study of 406 women given "light chemo" — paclitaxel plus Herceptin for 12 weeks, followed by nine months of Herceptin alone. More than three years later, only four had cancer recur in the same breast, and two had recurrences in other places.

"This is likely to become a new standard," Winer said.

The cancer conference is sponsored by the American Association for Cancer Research, Baylor and the UT Health Science Center.

  • get related content delivered to your inbox

  • manage my email subscriptions

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

question of the day

Poll: How much money do you plan to spend per person at the State Fair?

Weekly Question

ADVERTISEMENT

ADVERTISEMENT

 
Close